Literature DB >> 14623701

The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease.

Jeffrey L Sugarman1, Joachim W Fluhr, Ashley J Fowler, Thomas Bruckner, Thomas L Diepgen, Mary L Williams.   

Abstract

OBJECTIVES: Clinical scores used to assess the severity of atopic dermatitis (AD) rely entirely on subjective criteria to evaluate the severity of lesions and the extent of involvement. The aim of this study was to develop an objective measure of AD severity by measuring stratum corneum (SC) functions and by using computer-assisted estimates of involved body surface areas (BSAs).
DESIGN: Barrier function of the SC was assessed by measuring transepidermal water loss, and SC hydration was assessed by measuring capacitance. The extent of disease was assessed using a computer-assisted algorithm. PATIENTS: A total of 38 sequential volunteers aged 4 months to 18 years (25 girls, 13 boys) with mild to severe AD at a university outpatient pediatric dermatology clinic. MAIN OUTCOME MEASURES: The computer-assisted method for estimating BSA was compared with estimates using the "rule of nines." The Objective Severity Assessment of Atopic Dermatitis (OSAAD) score, derived from measurements of SC barrier function and SC hydration and normalized for extent of disease was compared with the Scoring Atopic Dermatitis (SCORAD) index.
RESULTS: Measurements of epidermal permeability barrier function and SC hydration correlated with clinical estimates of disease severity. The computer-assisted measurements of the extent of disease correlated with estimates derived from the rule of nines. The OSAAD scores correlated with the currently used instrument for AD severity, the SCORAD index.
CONCLUSION: The OSAAD is a new AD severity score that avoids the pitfalls of currently used subjective scoring systems by using objective measures.

Entities:  

Mesh:

Year:  2003        PMID: 14623701     DOI: 10.1001/archderm.139.11.1417

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  29 in total

Review 1.  Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms.

Authors:  Peter M Elias; Yutaka Hatano; Mary L Williams
Journal:  J Allergy Clin Immunol       Date:  2008-03-07       Impact factor: 10.793

Review 2.  Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Matthias Schmuth
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

Review 3.  Lipid abnormalities and lipid-based repair strategies in atopic dermatitis.

Authors:  Peter M Elias
Journal:  Biochim Biophys Acta       Date:  2013-10-12

Review 4.  Getting Drugs Across Biological Barriers.

Authors:  Rong Yang; Tuo Wei; Hannah Goldberg; Weiping Wang; Kathleen Cullion; Daniel S Kohane
Journal:  Adv Mater       Date:  2017-07-28       Impact factor: 30.849

Review 5.  Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Joan S Wakefield
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

Review 6.  Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis.

Authors:  Peter M Elias; Joan S Wakefield
Journal:  J Allergy Clin Immunol       Date:  2014-08-15       Impact factor: 10.793

7.  Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators.

Authors:  Yutaka Hatano; Mao-Qiang Man; Yoshikazu Uchida; Debra Crumrine; Theodora M Mauro; Kenneth R Feingold; Peter M Elias; Walter M Holleran
Journal:  J Allergy Clin Immunol       Date:  2009-10-08       Impact factor: 10.793

Review 8.  Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes.

Authors:  Kelvin Yin; Aaron G Smith
Journal:  Cell Mol Life Sci       Date:  2016-08-20       Impact factor: 9.261

9.  Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens.

Authors:  Tiffany C Scharschmidt; Mao-Qiang Man; Yutaka Hatano; Debra Crumrine; Roshan Gunathilake; John P Sundberg; Kathleen A Silva; Theodora M Mauro; Melanie Hupe; Soyun Cho; Yan Wu; Anna Celli; Matthias Schmuth; Kenneth R Feingold; Peter M Elias
Journal:  J Allergy Clin Immunol       Date:  2009-09       Impact factor: 10.793

Review 10.  Skin barrier function.

Authors:  Peter M Elias
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.